Vision's Clinical Research is categorized under Commercial Medical Research in Tucson, AZ and active since 2004.
Vision's Clinical Research was established in 2004, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Cynthia Goldberg, Owner at the company’s single location by writing to 5656 East Grant Road # 450, Tucson, Arizona AZ 85712 or by phoning (520) 546-4700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Vision's Clinical Research |
Contact Person: | Cynthia Goldberg, Owner |
Address: | 5656 East Grant Road # 450, Tucson, Arizona 85712 |
Phone Number: | (520) 546-4700 |
Website Address: | visionstucson.com |
Annual Revenue (USD): | Unknown |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 5417115 |
Share This Business: |
Vision's Clinical Research was started in 2004 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Cynthia Goldberg, Owner for inquiries that concern Vision's Clinical Research by calling the company number (520) 546-4700, as your correspondence is most welcome. Additionally, the physical location of the single location of Vision's Clinical Research can be found at the coordinates 32.25055,-110.87131 as well as the street address 5656 East Grant Road # 450 in Tucson, Arizona 85712.
For its online presence, you may visit Vision's Clinical Research’s website at visionstucson.com and engage with its social media outlets through on Twitter and on Facebook.